Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia

doi:10.3748/wjg.v19.i28.4504

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 28

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6487)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

431

HTML

3633

Figures (1-2)

244

Tables (1-2)

216

Sum=4524

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1164

Download

799

Sum=1963

Jul 28, 2013 (publication date) through Jan 2, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jul 28, 2013; 19(28): 4504-4510
Published online Jul 28, 2013. doi: 10.3748/wjg.v19.i28.4504

Table 2 Neurotensin receptor 1 expression n (%)

	Negative	1+	2+	3+
SAP	0	4 (23.53)	8 (47.06)	5 (29.41)
DALM	0	7 (41.42)	7 (41.42)	3 (17.65)
SCRC	0	0	1 (8.33)	11 (91.67)
CACRC	0	1 (7.69)	4 (30.77)	8 (61.54)

Comparison between colitis-associated dysplasia/carcinoma and sporadic dysplasia/carcinoma. Sporadic colorectal adenomatous polyp (SCRC) vs colitis-associated colorectal carcinoma (CACRC), P = 0.198; Dysplasia-associated lesions or masses (DALMs) vs CACRC, P = 0.028; DALMs vs sporadic colorectal carcinomas (SAPs), P = 0.50.

Citation: Gui X, Liu S, Yan Y, Gao Z. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia. World J Gastroenterol 2013; 19(28): 4504-4510
URL: https://www.wjgnet.com/1007-9327/full/v19/i28/4504.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i28.4504